We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $837M
1-Year Est. Return 25.51%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+25.51%
3 Year Est. Return
+63.76%
5 Year Est. Return
+90.36%
10 Year Est. Return
AUM
$633M
AUM Growth
+$22.6M
Cap. Flow
+$12.5M
Cap. Flow %
1.98%
Top 10 Hldgs %
45.8%
Holding
357
New
21
Increased
183
Reduced
81
Closed
51

Top Buys

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$7.7M
2
PFE icon
Pfizer
PFE
+$4.75M
3
TD icon
Toronto Dominion Bank
TD
+$3.61M
4
BCE icon
BCE
BCE
+$2.99M
5
NVO
Novo Nordisk
NVO
+$2.48M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 16.95%
3 Communication Services 13.34%
4 Financials 12.69%
5 Energy 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOA
1
North American Construction
NOA
$377M
$43.9M 6.94%
2,040,138
+33,881
+2% +$664K
GIB icon
2
CGI
GIB
$13.9B
$43.9M 6.93%
401,362
-7,485
-2% -$841K
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$31.2M 4.92%
53,235
-1,701
-3% -$998K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$3.91T
$28.9M 4.56%
152,419
-2,254
-1% -$394K
MSFT icon
5
Microsoft
MSFT
$2.84T
$28.8M 4.55%
68,371
-920
-1% -$392K
OLLI icon
6
Ollie's Bargain Outlet
OLLI
$4.01B
$27.3M 4.3%
248,467
-1,681
-0.7% -$167K
ULTA icon
7
Ulta Beauty
ULTA
$20.4B
$23.2M 3.67%
53,444
-224
-0.4% -$86.8K
OCSL icon
8
Oaktree Specialty Lending
OCSL
$1.03B
$22.8M 3.61%
1,495,190
+13,949
+0.9% +$223K
ABBV icon
9
AbbVie
ABBV
$458B
$22.7M 3.59%
127,816
-2,817
-2% -$518K
CTSH icon
10
Cognizant
CTSH
$21.5B
$17.4M 2.74%
225,614
-2,377
-1% -$186K
CSCO icon
11
Cisco
CSCO
$450B
$15.4M 2.43%
259,967
-2,067
-0.8% -$118K
RY icon
12
Royal Bank of Canada
RY
$291B
$15.3M 2.42%
127,061
-91
-0.1% -$11.2K
QIPT
13
DELISTED
Quipt Home Medical
QIPT
$13.6M 2.15%
4,470,799
-77,414
-2% -$208K
CVS icon
14
CVS Health
CVS
$137B
$13.5M 2.14%
301,743
+28,500
+10% +$1.6M
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$9.88M 1.56%
174,623
+2,199
+1% +$123K
UI icon
16
Ubiquiti
UI
$31.8B
$9.83M 1.55%
29,623
-540
-2% -$163K
CM icon
17
Canadian Imperial Bank of Commerce
CM
$107B
$9.8M 1.55%
154,944
-2,289
-1% -$145K
INDV icon
18
Indivior Pharmaceuticals
INDV
$4.79B
$9.3M 1.47%
+748,486
New +$7.7M
JNJ icon
19
Johnson & Johnson
JNJ
$635B
$9.07M 1.43%
62,692
-301
-0.5% -$46.6K
C icon
20
Citigroup
C
$222B
$8.81M 1.39%
125,209
-2,831
-2% -$191K
PYPL icon
21
PayPal
PYPL
$49.5B
$8.77M 1.39%
102,790
-8,821
-8% -$742K
PFE icon
22
Pfizer
PFE
$140B
$7.85M 1.24%
295,892
+175,273
+145% +$4.75M
GOOG icon
23
Alphabet (Google) Class C
GOOG
$3.9T
$7.73M 1.22%
40,572
-982
-2% -$173K
TD icon
24
Toronto Dominion Bank
TD
$198B
$6.64M 1.05%
124,751
+64,399
+107% +$3.61M
TSCO icon
25
Tractor Supply
TSCO
$16.3B
$6.17M 0.97%
116,265
-2,130
-2% -$120K

Similar funds

Claret Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Claret Asset Management held 357 positions worth $633M, up 3.7% from $611M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Claret Asset Management's Q4 2024 filing shows 21 new, 183 increased, 81 reduced and 51 closed positions. Its largest new stake was Indivior Pharmaceuticals: 748,486 shares worth $9.3M. The largest sale was Paramount Global Class B, an estimated $2.58M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Claret Asset Management's largest Q4 2024 buy was Indivior Pharmaceuticals: 748,486 shares worth $9.3M.
  • Claret Asset Management added most to Pfizer in Q4 2024, an estimated $4.75M increase.
  • Claret Asset Management's biggest Q4 2024 reduction was Paramount Global Class B, cutting an estimated $2.58M.
  • Claret Asset Management fully exited Primo Water Corporation in Q4 2024, selling an estimated $900K.
  • Claret Asset Management's ten largest holdings make up 46% of its $633M portfolio in Q4 2024.
  • Claret Asset Management opened 21 new positions and closed 51 in Q4 2024.
  • Claret Asset Management's portfolio value rose 3.7% quarter-over-quarter to $633M.

Based on Claret Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.